As the clinical trial industry focuses on finding a “new normal” during the COVID-19 pandemic, we are focused on how Medrio can assist in your trials now, when remote services are needed more than ever. Paper studies are at a stand-still and that’s leaving sponsors, CRO’s and sites scrambling to find a path forward.
Higher Quality Data
While it’s been proven that electronic patient reporting yields higher quality data than paper-based studies, some are still resistant to adopting ePRO for their trials. COVID-19 has turned paper trials upside down. Start-up costs with ePRO have traditionally been more expensive than paper-based studies, but only looking at start-up costs is shortsighted. Trials that have utilized ePRO have reduced their overall trial costs long-term.
Increased Compliance
Pandemic aside, ePRO trials have proven to be more effective, by providing better data and by producing significantly higher protocol compliance by the patient. Compliance is increased through alerts and notifications sent directly to a patient’s device. In addition, BYOD, or bring your own device, enables patients to be more comfortable with web or application-based systems by accessing them through their personal devices.
Reduced Reconciliation
Another barrier to ePRO adoption is the lack of paper backup. Medrio offers a unified system encompassing ePRO, Direct Data Capture (DDC), and eConsent within our EDC. We are the only provider that offers offline capabilities to reduce paper CRFs, patient surveys collected, and time spent reconciling paper versus electronic data capture.
Our Mission
Medrio’s mission is to create a healthier future through clinical trial technology. At the heart of that mission are the patients. With endpoints constantly increasing and regulatory statutes perpetually changing, it’s easy to get wrapped up in the data, but the end goal is to get new treatments and therapeutics to the people who need them most. Why not design your trial with the patient in mind? As technology advances, so do a patient’s expectations. Patient centricity shouldn’t be a new way of thinking, but rather the primary way of thinking.
Decentralization is the way of the future, and the future is now.
